Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Transplantation|February 27, 1995
A prospective randomized trial of FK506-based immunosuppression after renal transplantationR Shapiro, M L Jordan, V P Scantlebury, et al.Transplantation|March 8, 2000
Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist?R Shapiro, M L Jordan, V P Scantlebury, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-upH P Tan, J Donaldson, A Basu, et al.Transplantation|August 15, 2001
Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipientsP P Luke, V P Scantlebury, M L Jordan, et al.Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)|March 7, 2000
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patientsA Soran, R Shapiro, H Basar, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 31, 2014
European perspective on human polyomavirus infection, replication and disease in solid organ transplantationH H Hirsch, N Babel, P Comoli, et al.Transplantation|May 8, 1999
Renal transplantation in recipients over the age of 60: the impact of donor ageH Basar, A Soran, R Shapiro, et al.Clinical Transplants|October 20, 2000
Simultaneous pancreas-kidney transplantation at the University of PittsburghR Shapiro, M L Jordan, V P Scantlebury, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapyH P Tan, D J Kaczorowski, A Basu, et al.Transplantation|November 15, 1996
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppressionR Shapiro, C Vivas, V P Scantlebury, et al.Pageof 9